
CureVac B.V (CVAC) Earnings Dates & Reports
CureVac B.V (CVAC) Most Recent Earnings
Report Date
Period EndingQ3 2025
Est. EPS-$0.17
Actual EPS$1.41
EarningsBeat
CureVac B.V (CVAC) Earnings
View the latest CureVac B.V (CVAC) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in CureVac B.V (CVAC)
Order type
Buy in
Order amount
Est. shares
0 shares
CureVac B.V (CVAC) Earnings per Share (EPS) History
Signup for full accessBrowse free
CureVac B.V (CVAC) Latest Earnings
The value each CVAC share was expected to gain vs. the value each share gained.
CureVac B.V (CVAC) reported its most recent earnings on for Q3 2025, posting earnings per share (EPS) of $1.41. This exceeded analysts' expectations of -$0.17 by 929.41%, marking a Beat.
For comparison, CureVac B.V reported EPS of -$0.24 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.27.
CureVac B.V (CVAC) Earnings History
CureVac B.V (CVAC) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the CureVac B.V’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
CureVac B.V (CVAC) Earnings FAQs
CureVac B.V (CVAC) last reported earnings on Nov 24, 2025 for Q3 2025, posting an EPS of $1.41, which Beat the estimate of -$0.17 by 929.41%.
For Q3 2025, CureVac B.V (CVAC) reported an EPS of $1.41, exceeding analysts' estimate of -$0.17 by 929.41%.
For Q3 2025, CureVac B.V (CVAC) Beat expectations with an actual EPS of $1.41 vs. an estimated EPS of -$0.17.
Following the last earnings report on Nov 24, 2025, CureVac B.V (CVAC)'s stock price moved — from — to —.
The next CureVac B.V (CVAC) earnings call is scheduled for Apr. 9, 2026, where executives will discuss financial results and outlook.